 | |
| Names | |
|---|---|
| IUPAC name 2-bromo-N-[2-[4-[[2-hydroxy-3-(2-prop-2-enylphenoxy)propyl]amino]-4-methylcyclohexyl]propan-2-yl]acetamide | |
| Identifiers | |
3D model (JSmol) | |
| Abbreviations | BAAM, BrAAM |
| ChEMBL | |
| ChemSpider |
|
| MeSH | Bromoacetylalprenololmenthane |
| |
| |
| Properties | |
| C24H37BrN2O3 | |
| Molar mass | 481.475 g·mol−1 |
| logP | 4.14 |
| Acidity (pKa) | 13.844 |
| Basicity (pKb) | 0.153 |
Except where otherwise noted, data are given for materials in theirstandard state (at 25 °C [77 °F], 100 kPa). | |
Bromoacetylalprenololmenthane (BAAM orBrAAM) is aβ adrenergic receptor agonist.[1]
 | Thisdrug article relating to thecardiovascular system is astub. You can help Wikipedia byadding missing information. |
